World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

Bioprocess and manufacturing at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

62 organizations at World Vaccine Congress Europe 2026 present work in bioprocess & manufacturing: 46 suppliers and service providers, 8 vaccine and drug developers, 6 public-health and non-profit bodies and 2 academic bodies. Between them they bring 71 presentations to the program. Most represented: GSK (7 on the program), IAVI (5 on the program), CEPI (4 on the program). As of Oct 12, 2026.

All 268 organizations at World Vaccine Congress Europe 2026 →

Format
Top represented
Showing 1–10 of 62 organizations
OrganizationWorld Vaccine Congress Europe 2026 Attendance
GSK
London, United Kingdom
Panel
Mon Oct 19
12:15
Panel: Building Next-Generation Vaccine Platforms: Innovation, Stability, and Scalability
Workshop: Platform Technologies · with CEPI, IAVI, The Francis Crick Institute +1 more
Talk
Mon Oct 19
15:00
Panel: Global Vaccine Access: Balancing Speed and Safety
How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks.
with European Medicines Agency, BioNTech, Gates Medical Research Institute +1 more
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with UK Health Security Agency (UKHSA), CSL Seqirus, University of Oxford +1 more
Talk
Wed Oct 21
13:15
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, IAVI +2 more
Talk
Wed Oct 21
15:00
Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling
Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them.
with Swedish Medical Products Agency, Sanofi, European Medicines Agency
IAVI
New York, NY
Public health & non-profit
Non-profit research organization developing vaccines and antibodies for HIV, tuberculosis and emerging infectious diseases.
Talk
Mon Oct 19
11:30
Vaccine development using recombinant Vesicular Stomatitis Virus (VSV) as platform technology
Workshop: Platform Technologies
Talk
Mon Oct 19
11:45
rVSV technology for Bundibugyo vaccine development
Workshop: Platform Technologies
Panel
Mon Oct 19
12:15
Panel: Building Next-Generation Vaccine Platforms: Innovation, Stability, and Scalability
Workshop: Platform Technologies · with CEPI, GSK, The Francis Crick Institute +1 more
Session
Wed Oct 21
10:30
Track Chair
Bioprocess & Manufacturing
Session
Wed Oct 21
12:15
Track Chair
Bioprocess & Manufacturing
Panel
Wed Oct 21
13:15
Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle
How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers.
with World Health Organization (WHO), World Organisation for Animal Health (WOAH), PATH +2 more
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, GSK +2 more
CEPI
Oslo, Norway
Public health & non-profit
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats.
Panel
Mon Oct 19
12:15
Panel: Building Next-Generation Vaccine Platforms: Innovation, Stability, and Scalability
Workshop: Platform Technologies · with GSK, IAVI, The Francis Crick Institute +1 more
Talk
Tue Oct 20
16:00
Panel: Expanding the Access & Impact of Adjuvants
How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries.
with Baylor College of Medicine, Croda Pharma, Vaccine Formulation Institute +1 more
Panel
Wed Oct 21
13:30
Panel: Controlled Human Infection Models (CHIMs): Evidence, Ethics and the Next Phase of Vaccine R&D
How studies that deliberately infect volunteers guide vaccine decisions, and what must be in place before using them for new diseases.
with International Vaccine Institute, UK Health Security Agency (UKHSA), Centre for Human Drug Research (CHDR) +1 more
Panel
Wed Oct 21
16:00
Europe’s Vision for Global Health Security: Designing Sustainable Vaccine Financing and Preparedness Systems
How Europe can shift vaccine funding from crisis-driven spending to long-term plans, using tools like joint purchasing and advance promises to buy.
with University of Groningen, UK Department of Health and Social Care, European Commission
Supply, safety & access
European Commission
Brussels, Belgium
Public health & non-profit
Executive body of the European Union, setting EU health, health-security and veterinary policy.
Talk
Wed Oct 21
09:00
The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World
How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home.
with Hilleman Laboratories, Access to Medicine Foundation, UNICEF +1 more
Supply, safety & accessBioprocess & manufacturing
Talk
Wed Oct 21
10:45
Panel
Wed Oct 21
11:00
Panel: Rethinking Livestock Vaccination for Emerging Threats
How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives.
with Boehringer Ingelheim, World Organisation for Animal Health (WOAH), SciEthiQ +1 more
Panel
Wed Oct 21
16:00
Europe’s Vision for Global Health Security: Designing Sustainable Vaccine Financing and Preparedness Systems
How Europe can shift vaccine funding from crisis-driven spending to long-term plans, using tools like joint purchasing and advance promises to buy.
with University of Groningen, CEPI, UK Department of Health and Social Care
Supply, safety & access
Johnson & Johnson
New Brunswick, NJ
Session
Tue Oct 20
14:00
Track Chair
Formulation & Bioprocess
Session
Tue Oct 20
16:00
Track Chair
Formulation & Bioprocess
BiotechShowcase sponsor
Develops mucosal vaccines against serious infectious diseases on a proprietary platform of outer membrane vesicles (OMVs).
Booth
Exhibiting (no floor booth listed)
Talk
Mon Oct 19
10:30
Novel OMV platform for mucosal vaccines
Workshop: Platform Technologies
Talk
Wed Oct 21
10:30
From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality
How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials.
with NorthX Biologics
Inimmune
Missoula, MT
Biotech
Biotech designing and developing TLR agonist adjuvants and immunotherapeutics.
Talk
Mon Oct 19
14:00
Workshop Leader’s Opening Remarks
Workshop: Vaccine Delivery
Talk
Wed Oct 21
10:45
Innovative Adjuvants for Global Health
Bioprocess & Manufacturing · with SPI Pharma
HL
Hilleman Laboratories
Singapore, Singapore
BiotechShowcase sponsor
Vaccine research and development organization, founded by MSD and Wellcome, developing affordable vaccines for low- and middle-income countries.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
11:30
Working Group: Partnerships for Prevention: Accelerating Vaccines to Curb Antimicrobial Resistance
How partnerships across sectors could speed up and widen access to vaccines against drug-resistant bacteria, such as a maternal Klebsiella vaccine for newborns.
with CARB-X, World Health Organization (WHO), University of Maryland School of Medicine +1 more
Infectious disease & AMRSupply, safety & access
Talk
Wed Oct 21
09:00
The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World
How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home.
with European Commission, Access to Medicine Foundation, UNICEF +1 more
Supply, safety & accessBioprocess & manufacturing
Talk
Wed Oct 21
12:15
Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs
Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need.
with International Vaccine Institute, Luipaard, Health Emergency Preparedness and Response Authority
Academic
Medical school whose Texas Children's Hospital Center for Vaccine Development develops low-cost vaccines for neglected and emerging diseases.
Talk
Tue Oct 20
10:15
One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime
Whether combining several vaccines into one shot raises coverage at every age, and how to keep such shots safe, effective and widely available.
with PATH, MHRA, Moderna +2 more
Infectious disease & AMR
Talk
Tue Oct 20
16:00
Panel: Expanding the Access & Impact of Adjuvants
How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries.
with CEPI, Croda Pharma, Vaccine Formulation Institute +1 more
Talk
Wed Oct 21
14:45
Update on Hookworm Vaccine Initiative
Emerging & Infectious Diseases
Croda Pharma
Snaith, United Kingdom
Bioprocess & manufacturingSilver sponsor
Supplies adjuvant systems, lipids for nucleic acid delivery and high-purity excipients for vaccine and drug formulation.
Booth
Exhibiting at Booth 214
Talk
Tue Oct 20
14:00
Architects of immunity: Why adjuvant supply should be the first act of innovation
Formulation & Bioprocess
Talk
Tue Oct 20
16:00
Panel: Expanding the Access & Impact of Adjuvants
How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries.
with Baylor College of Medicine, CEPI, Vaccine Formulation Institute +1 more

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in bioprocess & manufacturing

Tell us what you sell and we’ll find the people at organizations working on bioprocess & manufacturing most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse World Vaccine Congress Europe 2026 by

Exhibit hall

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction